Alteralia's private debt fund has completed its eighth investment by providing a long-term loan to finance the buy-out of Pronokal by Abac Capital and the management team.

Target Information

Pronokal, established in 2004 and headquartered in Barcelona, is a prominent player in the nutrition sector, specializing in protein diet treatments that require medical prescription of the company's proprietary products. With an extensive portfolio consisting of over 200 unique products, Pronokal prides itself on having a dedicated team of more than 100 dieticians who provide continuous support and coaching to clients throughout their treatment journeys.

As of 2016, Pronokal reported revenues of approximately €41 million, with an impressive 50% of its earnings generated from international markets across 15 countries. This robust global presence underscores the company's commitment to expanding its influence and reach within the health and wellness industry.

Industry Overview in Spain

Spain's nutrition industry is experiencing significant growth, driven by an increasingly health-conscious population seeking effective dietary solutions. The demand for specialized n